Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

BGJ398 in Combination With Imatinib Mesylate in Patients With Untreated Advanced Gastrointestinal Stromal Tumor (GIST)

Phase 1

Completed

Conditions: Advanced Gastrointestinal Stromal Tumor (GIST)

Interventions: Drug: BGJ398
Drug: Imatinib Mesylate

First Posted Date: 2014-10-06

Last Posted Date: 2020-03-30

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 16

Registration Number: NCT02257541

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
Memorial Sloan Kettering Westchester, Harrison, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center @ Suffolk, Commack, New York, United States

and more 4 locations

Gemcitabine, Trastuzumab, and Pertuzumab in the Treatment of Metastatic HER2-Positive Breast Cancer After Prior Trastuzumab/Pertuzumab, or Pertuzumab Based Therapy

Phase 2

Active, not recruiting

Conditions: Metastatic HER2-Positive Breast Cancer

Interventions: Drug: Gemcitabine
Drug: Trastuzumab
Drug: Pertuzumab

First Posted Date: 2014-09-30

Last Posted Date: 2025-05-21

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 45

Registration Number: NCT02252887

Locations: 🇺🇸
Memorial Sloan Kettering at Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸
Hartford Healthcare Cancer Institute @ Hartford Hospital, Hartford, Connecticut, United States
🇺🇸
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States

and more 2 locations

Care For The Cancer Caregiver: A Meaning-Based Workshop To Help Manage Caregiver Burden

Not Applicable

Completed

Conditions: Caregivers

Interventions: Other: webcasts
Behavioral: Assessments
Other: Usual care

First Posted Date: 2014-09-26

Last Posted Date: 2018-08-10

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 88

Registration Number: NCT02250911

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Assessing Insulin Sensitivity and Diabetes Risk in Childhood Cancer Survivors Treated With Abdominal Irradiation

Completed

Conditions: Childhood Cancer Survivors Treated With Abdominal Radiation

First Posted Date: 2014-09-25

Last Posted Date: 2019-10-15

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 42

Registration Number: NCT02248779

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Local Control With Reduced-dose Radiotherapy for High-Risk Neuroblastoma

Not Applicable

Completed

Conditions: Neuroblastoma

Interventions: Radiation: External beam radiotherapy
Radiation: proton beam RT

First Posted Date: 2014-09-22

Last Posted Date: 2025-05-06

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 78

Registration Number: NCT02245997

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Exercise and QUality Diet After Leukemia: The EQUAL Study

Not Applicable

Active, not recruiting

Conditions: Adult Survivors of Childhood Leukemia

Interventions: Behavioral: individual diet & physical activity counselor and website through Healthways at Hopkins
Behavioral: self directed weight loss
Behavioral: questionnaires
Other: fasting blood draw, measurement of height, weight and waist circumference, and blood pressure

First Posted Date: 2014-09-19

Last Posted Date: 2024-07-15

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 358

Registration Number: NCT02244411

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Two Stage Study Of Single Dose PEGPH20 And Cetuximab In Patients With Pancreatic Adenocarcinoma Prior To Surgical Resection

Not Applicable

Completed

Conditions: Pancreatic Cancer

Interventions: Drug: PEGPH20
Drug: Cetuximab
Device: DW & DCE-MRI
Other: blood draws

First Posted Date: 2014-09-16

Last Posted Date: 2017-09-27

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 2

Registration Number: NCT02241187

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Nintedanib in Patients With Advanced Esophagogastric Cancer

Phase 2

Completed

Conditions: Esophagogastric Adenocarcinoma

Interventions: Drug: Nintedanib

First Posted Date: 2014-09-09

Last Posted Date: 2021-01-25

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 34

Registration Number: NCT02234596

Locations: 🇺🇸
Memoral Sloan Kettering Cancer Center, Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Cancer Center @ Suffolk, Commack, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center 1275 York Avenue, New York, New York, United States

and more 3 locations

Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330) in Patients With Myelodysplastic Syndromes

Phase 2

Completed

Conditions: Myelodysplastic Syndromes

Interventions: Drug: selinexor (KPT-330)

First Posted Date: 2014-08-29

Last Posted Date: 2022-03-09

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 25

Registration Number: NCT02228525

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Evaluate the Efficacy of MEDI4736 in Immunological Subsets of Advanced Colorectal Cancer

Phase 2

Completed

Conditions: Advanced Colorectal Cancer

Interventions: Drug: MEDI4736

First Posted Date: 2014-08-28

Last Posted Date: 2021-06-18

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 16

Registration Number: NCT02227667

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy